View More

Experience CUREXO Medical Robots at More Hospitals

Consecutively providing "CUVIS-spine" and "Morning Walk" to domestic, highest performing general hospitalsCUREXO's medical robots are expected to vitalize robot rehabilitation treatment sites.CUREXO(060280), a medical robot specialized company, has revealed that it will supply a spinal surgery robot "CUVIS-spine" to Severance Hospital, walking rehabilitation robot "Morning Walk" to Jeonbuk National University Hospital and Saerom Rehabilitation & Nursing Hospital each, as part of the "medical rehabilitation robot supply project" jointly promoted by the Ministry of Trade, Industry and Energy, the Korea Institute for Robot Industry Advancement, and the National Rehabilitation Center.The "medical rehabilitation robot supply project" aims to prove the efficiency of robot rehabilitation and distribute them to various medical sites by discovering robots with high market potential and demonstrate testing them at domestic medical institutions.CUREXO's robot for spinal surgery "CUVIS-spine (left)" and for walking rehabilitation "Morning Walk (right)"According to CUREXO, CUVIS-spine is a robot for spinal surgery which has been supplied with a contract for research and development between Severance Hospital and CUREXO. Currently, Severance Hospital is operating the most robotic surgeries among the highest performing general hospitals in the country.CUVIS-spine has acquired licensing from the Korean Ministry of Food and Drug Safety in December 2019 and the CE certification from Europe this May, and it is now looking forward to U.S FDA's licensing after completing all procedures for the approval.A robot for walking rehabilitation Morning Walk has been installed in major rehabilitation hospitals across the country, starting from the National Rehabilitation Center in 2015 and to hospitals, including Jeonbuk National University Hospital and Saerom Rehabilitation & Nursing Hospital. Now, a total of 14 Morning Walks are in use for treating patients with lower extremity disabilities. Moreover, the upgraded version of Morning Walk, "Morning Walk S200," is completed developing and will prepare for licensing in the country within the second half of this year."As we supply to Korea's advanced general hospitals some various medical robots such as "CUVIS-spine" and "Morning Walk," which we've developed with our own technologies over a long period, I believe we are taking a first step toward becoming medical robot specialized company," Jaejun Lee, the CEO of CUREXO said. "I am expecting an increase in sales along with profitability improvements, as 'CUVIS-Joint,' in addition to domestic supply, successfully signed a long-term contract with 'Meril Healthcare,' the largest implant firm in India," he added.Meanwhile, CUREXO is actively marketing its various medical robots to Korean hospitals and overseas distributors and is determined to focus on achieving additional sales in the next half of the year, excluding already fixed domestic and overseas contracts.Source: http://www.k-health.com/news/articleView.html?idxno=49552

View More

CUREXO Signs Sales Agreement with Meril

Curexo signed a contract with Meril Healthcare in India to sell at least 53 CUVIS-joint surgical robots by the end of 2025.CUVIS-joint is designed to cut bone, allowing precise implant insertion. It enables patient-specific procedures based on CT images and is equipped with AI Auto Segmentation as well as a guide on choice of implant size and location to cut bones.The company is pursuing an open platform solution compatible with a variety of implants in Korea and abroad."As India is also suffering from ongoing COVID-19 pandemic, we are planning to support sales activities of Meril Healthcare via online training for doctors and local workers in operations after the first export to India. Through this solution, we believe CUVIS-joint's instructions are easy to learn and many functions will help them," a CUREXO official said.In addition, CUVIS-joint is preparing for CE Mark approval in Europe and FDA 510(k) clearance by 1H21. The company submitted the device for FDA 510(k) clearance for the CUVIS-spine robot last month.By Julie A. Vetalicehttps://www.orthoworld.com/curexo-gains-ce-mark-approval-for-cuvis-spine-robot/

View More

CUREXO Gains CE Mark Approval for CUVIS-spine Robot

Curexo received approval under the CE Mark for the CUVIS-spine surgical robot. The company is also planning to apply for FDA clearance.CUVIS-spine guides and supports the pedicle screw to the correct position using a robotic arm, one-step surgical tools and a real-time location sensor. Real-time patient position monitoring can correct the surgical plan in real time, and can help reduce radiation exposure for the patient and O.R. staff.CUVIS-spine provides imaging compatibility on not only C-arms, but also O-arms. The device received approval by Korea's Ministry of Food and Drug Safety and launched late last year in the region.The company is also developing CUVIS-joint for potential launch in 2020.According to the CEO of CUREXO, "Certifying the CE certificate for CUVIS-spine is another big step taken after last year's MFDS certificate. Also, achieving the CE certificate for the CUVIS-spine is meaningful because now CUREXO is aiming for the global market with a self-developed surgical robot. The following task will be FDA approval and entering the U.S. market, which is number one in surgical robots.By Julie A. Vetalicehttps://www.orthoworld.com/curexo-gains-ce-mark-approval-for-cuvis-spine-robot/

View More

CUREXO Launches Robot-Assisted Spine Surgery Device

Curexo launched the CUVIS-spine robot-assisted spine surgery device following approval by Korea's Ministry of Food and Drug Safety.CUVIS-spine guides and supports the pedicle screw to the correct position using a robotic arm, one-step surgical tool and real-time location sensor. Real-time patient position monitoring can correct the surgical plan in real time, and can help reduce radiation exposure for the patient and O.R. staff.Curexo seeks to establish an overseas sales agency, as it expects to receive CE Mark approval in 1H20 and will also apply for FDA clearance.The company is also developing CUVIS-joint for launch in 2020.By Julie A. VetaliceSource: https://www.orthoworld.com/curexo-launches-robot-assisted-spine-surgery-device/